Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pleural effusion in plasmacytic leukemia]

M Matýsková1, E Krahulcová, A Buliková

  • 1Oddĕlení klinické hematologie FN, Brno-Bohunice.

Vnitrni Lekarstvi
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monoclonal gammopathy of clinical signifi cance with osteosclerotic lesions - a case report and a literature review.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2024
Same author

Increasing procoagulant activity of circulating microparticles in patients living with HIV.

Medecine et maladies infectieuses·2019
Same author

[Acquired haemophilia A].

Vnitrni lekarstvi·2012
Same author

Metabolomic fingerprinting employing DART-TOFMS for authentication of tomatoes and peppers from organic and conventional farming.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2012
Same author

[Prognostic significance of morphology in multiple myeloma].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2012
Same author

[Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide].

Vnitrni lekarstvi·2012
Same journal

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023
Same journal

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023
Same journal

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023
Same journal

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023
Same journal

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023
Same journal

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023
See all related articles

Plasmacytic leukemia, a rare multiple myeloma complication, can manifest as pleural effusion. This case highlights that plasmatic exudate indicates a poor prognosis, necessitating aggressive treatment for this rare leukemia.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Multiple myeloma primarily affects bone marrow and surrounding bone structures.
  • Plasmacytic leukemia is a rare, aggressive variant of multiple myeloma.

Observation:

  • A 68-year-old female presented with anemia and a right-sided pleural effusion containing plasma cells.
  • The pleural effusion initially responded to chemotherapy and intrapleural cytostatics.

Findings:

  • Despite initial remission, the patient experienced a relapse with recurrent pleural effusion and bone marrow failure.
  • The presence of a plasmatic exudate is a critical indicator of a poor prognosis in plasmacytic leukemia.

Implications:

  • Plasmacytic leukemia with pleural effusion requires prompt and aggressive therapeutic strategies.

Related Experiment Videos

  • Early recognition of plasmatic exudate is crucial for patient management and treatment decisions.